Skip to main content
Skip to navigation

FDA Guidance Provides Clarity to Drug and Medical Device Companies

By Jaclyn Jaeger2014-04-01T00:00:00

THIS IS MEMBERS-ONLY CONTENT

You are not logged in and do not have access to members-only content.

If you are already a registered user or a member, SIGN IN now.

Related articles

Article
Drug, Device Companies Face New FDA Electronic Submissions

2015-06-30T09:45:00Z By Joe Mont

The Food and Drug Administration is overhauling how it accepts submissions for a host of filing requirements imposed on drug and medical device makers. For many, this will be the first time the submissions have ever been filed electronically. While the move away from paper documents may ultimately be advantageous ...
News Brief
CFPB drops $95M enforcement action against Navy Federal, without explanation

2025-07-07T19:02:00Z By Aaron Nicodemus

The Consumer Financial Protection Bureau has dropped a $95 million enforcement action against Navy Federal Credit Union, the latest regulatory pullback by the agency under President Donald Trump.
Article
FCA drops ‘naming and shaming’ approach – except in ‘exceptional circumstances’

2025-07-07T17:45:00Z By Neil Hodge

The UK’s financial regulator has had a rough ride over the past couple of years as its strategy to “name and shame” firms it opened investigations into was widely slammed by the industry and lawmakers over concerns that companies could be unfairly maligned.